Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.414 EUR | +1.72% | -1.90% | -10.00% |
Apr. 05 | GenSight: financial visibility assured until the end of April | CF |
Mar. 25 | GenSight: share price falls, limited financial visibility | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.00% | 34.52M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.86% | 22.2B | |
-16.53% | 21.23B | |
-8.49% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- SIGHT Stock
- News GenSight Biologics S.A.
- GenSight Biologics S A : Expects EU Decision on Eye Disorder Drug Lumevoq in Q4